2026-04-17T20:16:44Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1224872025-12-05T13:13:15Zcom_2072_1057col_2072_478798col_2072_478916col_2072_478917

What about HES in burn patients?: Evaluation of the actual evidence Guilabert, Patricia Abarca, Luis Martin, Nuria Usua, Gemma Barret Nerín, Juan Pedro Colomina Soler, M. J. (María José) Cremades Medicaments Malalts en estat crític Burns and scalds Drugs Critically ill Following the 2013 alert by the European Medicines Agency (EMA) discouraging the use of hydroxyethyl-starch solutions (HES) in critically ill and burn patients, most specialized units treating burn victims have stopped using HES in this population. But, how well-founded was the EMA alert in this specific type of patient? ... 2018-05-22T12:49:53Z 2019-05-31T05:10:12Z 2018-05 2018-05-22T12:49:53Z info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion 0305-4179 https://hdl.handle.net/2445/122487 676941 29029856 eng Versió postprint del document publicat a: https://doi.org/10.1016/j.burns.2017.09.023 Burns, 2018, vol. 44, num. 3, p. 489-493 https://doi.org/10.1016/j.burns.2017.09.023 cc-by-nc-nd (c) Elsevier B.V., 2018 http://creativecommons.org/licenses/by-nc-nd/3.0/es info:eu-repo/semantics/openAccess 5 p. application/pdf Elsevier B.V. Articles publicats en revistes (Ciències Clíniques)